Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 10.22 Delayed Data As of 4:00pm ET |  +0.21 / +2.10%Today’s Change | 7.09 Today|||52-Week Range 11.45 | +12.06% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 19.6B | 22.0B | 22.6B | 18.8B | |
| Cost of Goods Sold | 7.0B | 8.5B | 9.6B | 8.7B | ||
| Depreciation And Amortization | 1.3B | 1.5B | 2.1B | 1.8B | ||
| Operating Expenses | Gross Income | 11.3B | 11.9B | 10.9B | 8.3B | |
| General Expenses | 6.2B | 7.2B | 6.9B | 5.4B | ||
| Research And Development | 1.5B | 2.1B | 1.9B | 1.2B | ||
| Total Operating Expenses | 14.5B | 17.3B | 18.5B | 15.9B | ||
| Non-Operating Expenses | Operating Income | 5.1B | 4.7B | 4.0B | 2.9B | |
| Extraordinary Credit | 53.0M | -- | -- | 1.5B | ||
| Extraordinary Charge | -2.4B | -3.3B | -22.3B | -6.1B | ||
| Interest Expense On Debt | 464.8M | 692.2M | 878.8M | 1.1B | ||
| Equity In Earnings | -121.0M | 8.0M | -3.0M | -70.8M | ||
| Other Expenses | 60.0M | 88.3M | 515.0M | 153.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 2.4B | 826.6M | -18.5B | -2.6B | |
| Income Taxes | -633.8M | -522.6M | -1.9B | -194.4M | ||
| Minority Interest | -9.0M | -18.1M | -185.4M | -321.0M | ||
| Preferred Dividend | -15.0M | -261.8M | -262.0M | -248.2M | ||
| Net Income | 1.6B | 330.0M | -16.4B | -2.1B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 855.0M | 955.0M | 1.0B | 1.0B | |
| Shares To Calculate EPS Diluted | 864.0M | 961.0M | 1.0B | 1.0B | ||
| Earnings Per Share | EPS | $1.84 | $0.07 | -$16.39 | -$2.34 | |
| EPS Diluted | $1.82 | $0.07 | -$16.39 | -$2.34 | ||
